Tennis

The World Anti-Doping Agency (WADA) has yet to decide whether to appeal the decision to exonerate US Open champion Jannik Sinner of blame for his positive steroid tests. The agency has until the end of September to file an appeal.Sinner tested positive twice for an anabolic steroid in March but was not banned because the International Tennis Integrity Agency (ITIA) determined he was not to blame. Sinner's accepted explanation was that the banned performance-enhancer entered his system unintentionally through a massage from his physiotherapist, who used a spray containing the steroid to treat their own cut finger.The doping case was kept secret until last month's announcement, and the top-ranked Sinner went on to beat Taylor Fritz in the US Open final on Sunday.An appeal could jeopardize Sinner's US Open title, but Sinner and his legal team have provided detailed evidence that persuaded the ITIA and the tribunal judges that his explanation was credible.WADA and Nado Italia, Italy's anti-doping agency, are the only two agencies that could challenge the decision by an independent tribunal announced by the ITIA on Aug. 20. While the doping rules state that any other party with a right to appeal—such as Nado Italia—has 21 days to do so, WADA then gets another 21 days on top of that before its own window closes.Nado Italia has yet to file an appeal, and it is unclear whether the initial 21-day deadline expired Tuesday. The tennis integrity agency rulebook states that the deadline for filing an appeal to the Court of Arbitration for Sport (CAS) will be 21 days from the date of receipt of the reasoned decision in question by the appealing party.WADA then has another 21 days to file an appeal to the CAS in Lausanne, Switzerland.

Wimbledon Girls Finalist Nikola Bartunkova Provisionally Suspended for DopingNikola Bartunkova, the 18-year-old Czech tennis player who reached the Wimbledon girls' singles final last year, has been provisionally suspended by the International Tennis Integrity Agency (ITIA) for doping.The ITIA announced on Thursday that Bartunkova tested positive for trimetazidine, a banned heart medication, at tournaments in Trnava, Slovakia, and Maribor, Slovenia, in February and March, respectively. Trimetazidine, also known as TMZ, is a medication used to treat angina, a condition that causes chest pain. It is banned in sports because it can enhance endurance and performance.Bartunkova's positive tests are the latest in a series of high-profile cases involving TMZ. In 2021, Russian figure skater Kamila Valieva tested positive for the medication at the Beijing Winter Olympics, sparking a major controversy. Additionally, 23 Chinese swimmers were found to have used TMZ while preparing for the Tokyo Olympics.Bartunkova, who is currently ranked 282nd in the world, has been banned from all sanctioned tennis events pending an ITIA hearing. She reached the singles semifinals and the doubles final at the 2022 Junior Roland Garros, and was considered one of the rising stars in women's tennis.The ITIA's investigation into Bartunkova's case is ongoing, and it is unclear at this time what penalties she may face if found guilty of doping. The agency has a zero-tolerance policy for doping and has been cracking down on the use of performance-enhancing substances in tennis.The news of Bartunkova's suspension is a blow to the sport of tennis and raises concerns about the prevalence of doping among young athletes. It is important for all athletes to compete fairly and ethically, and the ITIA's efforts to combat doping are essential to maintaining the integrity of the sport.